Key Statistics for 4544
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4544
- Net Income (M/JPY)
Miraca Holdings Inc. develops, manufactures, exports, and imports clinical reagents, medical drugs, and medical equipment. The Company's clinical reagents are for cancer, malignant tumor, hypothyroidism, diabetes, and infectious diseases including AIDS. Miraca Holdings also conducts clinical tests for hospitals and medical organizations.
More Company Profile & Key Executives for 4544
|Hiromasa SuzukiPresident||Shinji OgawaSenior Executive Officer|
|Hiromitsu TazawaSenior Executive Officer||Takeshi KoyamaExecutive Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries